ENTITY
Biotest AG

Biotest AG (BIO GR)

14
Analysis
Health CareGermany
Biotest AG is a provider of plasma proteins and biological drugs. The Company has specialized primarily in the areas of clinical immunology, haematology and intensive medicine with a focus on treating diseases of the immune and haematopoietic systems. Biotest AG has production operations mainly in Europe and the US, and sells its products worldwide.
more
Refresh
20 Apr 2022 00:59

Liquid Universe of European Ordinary and Preferred Shares: April ‘22 Report

Spreads have generally tightened across our liquid universe in line with the recent market gains. Danieli, Media for Europe, Schroders and Sixt...

Share
bullishSchroders PLC
17 Mar 2022 23:36

Liquid Universe of European Ordinary and Preferred Shares: March '22 Report

Spreads have generally widened across our liquid universe in line with the recent market turmoil. Schroders non-voting and Sixt prefs. stand out...

Share
bullishSixt SE
16 Feb 2022 00:33

Liquid Universe of European Ordinary and Preferred Shares: February ‘22 Report

Spreads have generally tightened across our liquid universe, 410 bps in the case of Volkswagen. Spreads in Sixt (45.7%) and Schroders (37%) are...

Share
bearishBiotest AG
28 Jan 2022 17:05

Grifols/Biotest: Put Period

At the end of the additional offer acceptance period, Grifols has 96.2% of the voting rights and holds 69.72% of the share capital of Biotest. The...

Share
bullishRoche Holding
18 Dec 2021 00:27

Liquid Universe of European Ordinary and Preferred Shares: December Report

Spreads have generally tightened across our liquid universe, with some notorious exceptions such as BMW, Sixt and Volkswagen. Roche seems the most...

Share
x